{"DataElement":{"publicId":"2943067","version":"1","preferredName":"Other Myelodysplastic Syndrome And/Or Chronic Myeloproliferative Disease or Disorder Conversion Date","preferredDefinition":"The month, day, and year of the MDS / MPS transformation.","longName":"2940763v1.0:2532012v2.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2940763","version":"1","preferredName":"Other Myelodysplastic Syndrome And/Or Chronic Myeloproliferative Disease or Disorder Conversion","preferredDefinition":"Different than the one(s) previously specified or mentioned._A clonal hematopoietic disorder characterized by dysplasia and ineffective hematopoiesis in one or more of the hematopoietic cell lines.  The dysplasia may be accompanied by an increase in myeloblasts, but the number is less than 20%, which, according to the WHO guidelines, is the requisite threshold for the diagnosis of acute myeloid leukemia.  It may occur de novo or as a result of exposure to alkylating agents and/or radiotherapy.  (WHO, 2001)_Used to indicate that either or both of two items or options may be valid._Chronic myeloproliferative disorders (CMPDs) are clonal hematopoietic stem cell disorders, characterized by proliferation in the bone marrow of one or more of the myeloid (i.e., granulocytic, erythroid, and megakaryocytic) lineages.  The proliferation is associated with relatively normal, effective maturation, resulting in increased numbers of granulocytes, red blood cells, and/or platelets in the peripheral blood.  CMPDs are primarily diseases of adults._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._The act of changing the nature, form, function, or purpose of something to another.","longName":"2940765v1.0:2548407v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2940765","version":"1","preferredName":"Other Myelodysplastic/Myeloproliferative Disease And/Or Chronic Myeloproliferative Disorder Disease or Disorder","preferredDefinition":"Not otherwise specified.:A category of clonal myeloid disorders that have both myelodysplastic and chronic myeloproliferative features at the time of initial presentation.  (WHO, 2001) -- 2003:Used to indicate that either or both of two items or options:Chronic myeloproliferative disorders (CMPDs) are clonal hematopoietic stem cell disorders, characterized by proliferation in the bone marrow of one or more of the myeloid (i.e., granulocytic, erythroid, and megakaryocytic) lineages.  The proliferation is associated with relatively normal, effective maturation, resulting in increased numbers of granulocytes, red blood cells, and/or platelets in the peripheral blood.  CMPDs are primarily diseases of adults.  -- 2003:Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","longName":"2940765v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Myelodysplastic/Myeloproliferative Neoplasm","conceptCode":"C27262","definition":"A category of clonal hematopoietic disorders that have both myelodysplastic and myeloproliferative features at the time of initial presentation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Myeloproliferative Neoplasm","conceptCode":"C4345","definition":"A group of myeloid neoplasms that includes the following: chronic myeloid leukemia, BCR-ABL1 positive; polycythemia vera; essential thrombocythemia;  primary myelofibrosis; chronic neutrophilic leukemia; chronic eosinophilic leukemia, not otherwise specified; and myeloproliferative neoplasm, unclassifiable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73C7178F-E33A-7F8C-E040-BB89AD4324BD","latestVersionIndicator":"Yes","beginDate":"2009-09-17","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-09-17","modifiedBy":"ONEDATA","dateModified":"2009-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2548407","version":"1","preferredName":"Conversion","preferredDefinition":"The act of changing the nature, form, function, or purpose of something to another.","longName":"C52566","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Conversion","conceptCode":"C52566","definition":"The act of changing the nature, form, function, or purpose of something to another.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23BD8AFA-6CCE-0E52-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-03","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2006-12-03","modifiedBy":"ONEDATA","dateModified":"2006-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"73C6F405-BCC1-4555-E040-BB89AD4372F1","latestVersionIndicator":"Yes","beginDate":"2009-09-17","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-09-17","modifiedBy":"NYCHM","dateModified":"2017-03-01","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2532012","version":"2","preferredName":"Date","preferredDefinition":"The particular day, month and year an event has happened or will happen.","longName":"DATE","context":"NHLBI","contextVersion":"1","type":"Non-enumerated","dataType":"DATE","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"format":"YYYY-MM-DD","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008561","version":"1","preferredName":"Occurrences","preferredDefinition":"dates, times, and durations.","longName":"OCURS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B53BD1AB-090B-398B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-01-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2233081","version":"1","preferredName":"Date","preferredDefinition":"a particular day specified as the time something has, or will, happen.","longName":"C25164","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Date","conceptCode":"C25164","definition":"The particular day, month and year an event has happened or will happen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F90B5E56-BB15-0F45-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-09","modifiedBy":"ONEDATA","dateModified":"2005-06-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A1B282-BBA9-1DAB-E040-BB89AD4319DD","latestVersionIndicator":"Yes","beginDate":"2009-04-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-04-28","modifiedBy":"GDEEN","dateModified":"2024-02-23","changeDescription":"Created new version associated to different CD and Display Format as part of NMDP Date VD clean up 4/2009. mcooper Corrected def from KM change. AK 3/25/19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964931","version":"1","longName":"2014r1: MDS Pre-HSCT Data","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"mds_base_prep_trnf_sub_dt","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedDiagnosis:dateReported","type":"HCT_BRIDG","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the date of MDS / MP","type":"Preferred Question Text","description":"What was the date of MDS / MPS transformation?","url":null,"context":"NHLBI"},{"name":"Specify the date of  transformation:","type":"Alternate Question Text","description":"Specify the date of the transformation:","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2943067","type":"BRIDG Mapping Path","description":"PerformedDiagnosis.is Transformed Into [first] > PerformedDiagnosis.dateReported [second] WHERE PerformedDiagnosis.value [second] = \"Myelodysplasia / Myeloproliferative Disorders\"","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"73DE3F3F-FA3C-581C-E040-BB89AD437B33","latestVersionIndicator":"Yes","beginDate":"2009-09-18","endDate":"2014-05-21","createdBy":"ZHANGW","dateCreated":"2009-09-18","modifiedBy":"ALEYR","dateModified":"2019-04-13","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}